BCMA is overexpressed in myeloma PCs compared to normal ones, and its expression levels are elevated regardless of the stage of MGUS (monoclonal gammopathy of undetermined significance), SMM (smoldering multiple myeloma), and symptomatic MM[40-41]. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.